About Sebacia
Sebacia is a company based in Duluth (United States) founded in 2010. It operates as a B2B. Sebacia has raised $72.73 million across 10 funding rounds from investors including Hercules Capital, Square 1 Bank and Salem Partners. The company has 14 employees. Sebacia operates in a competitive market with competitors including Candesant, PhotoSonix Medical, Luma Therapeutics, Nano Ceuticals and Tiny Fat Eraser, among others.
- Headquarter Duluth, United States
- Employees 14
- SectorsHealthcare
- Website sebacia.com
- Social X
- Legal Name Sebacia, Inc.
- Total Equity Funding$72.73M (USD)
in 10 rounds
- Latest Funding Round$10M (USD), Series D
Sep 2019
- InvestorsHercules Capital
& 6 more
- Employee Count14
Funding Insights of Sebacia
Sebacia has successfully raised a total of $72.73M across 10 strategic funding rounds. The most recent funding activity was a Series D round of $10 million completed in September 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $72.73M
- Total Rounds 10
- Last Round Series D — $10M
- First Round $2.5M
(Jun 2010)
- Investors Count 7
All 10 funding rounds of Sebacia with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2019 | $10M | Series D | – | – | – |
| Jul 2017 | $21.14M | Series D | – | Versant Ventures | |
| Jul 2017 | $16M | Debt – Venture | – | – | |
| Aug 2015 | $10M | Debt – Conventional | – | – | |
| Jun 2015 | $12M | Series C | – | – | |
| Jun 2014 | $11M | Series B | – | – | – |
| Jul 2013 | $6.5M | Series B | – | – | – |
| Apr 2012 | $6.5M | Series A | – | – | – |
| Jun 2011 | $5.59M | Series A | – | – | – |
| Jun 2010 | $2.5M | Debt – Conventional | – | – | – |
7 investors in total: 7 institutional.
Investors in Sebacia
Sebacia has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Hercules Capital, Square 1 Bank and Salem Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm managing investments in biotechnology and pharmaceuticals since 1999. | – | versantventures.com | - | |
Life science & tech focused VC firm investing in the US | – | domainvc.com | Princeton, United States | |
Early-stage US healthcare investments are made by Accuitive Medical Ventures. | – | amvpartners.com | Duluth, United States | |
Venture debt financing is provided to companies in multiple sectors. | 2003 | htgc.com | Palo Alto, United States | |
- | – | innovation.partners.org | - | |
Regional investment bank | 1997 | salempartners.com | Los Angeles, United States | |
Venture debt, treasury, and cash management services are provided. | 2005 | square1bank.com | Durham, United States |
Investor details for Sebacia
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Sebacia
1 people are tracked at Sebacia (1 in leadership); the tracked headcount is 14.
| Name | Role | Group |
|---|---|---|
Anthony Lando | Founder, CEO | Leadership |
Complete people profiles for Sebacia
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Sebacia
3 dated milestones of Sebacia across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Sebacia is founded.
- Funding First funding round of $2.5M.
- Funding Latest funding round, Series D, of $10.0M.
Competitors of Sebacia
Sebacia operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Candesant, PhotoSonix Medical, Luma Therapeutics, Nano Ceuticals and Tiny Fat Eraser, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| candesant.com | 2016 | San Francisco, United States | $44.49M | 3 | Non-invasive energy device for hyperhidrosis treatment is provided. | |
| photosonixmed.com | 2014 | Ambler, United States | $2.39M | – | Combination Ultrasound & Phototherapy transducer for antibiotic resistant skin infections | |
| lumatherapeutics.com | 2013 | Millbrae, United States | $2.05M | – | Offers coal tar and light combination therapy for effective psoriasis treatment. | |
| nanoceuticals.net | 2018 | Goiania, Brazil | – | – | Nanoparticle-based products for cosmetics and health sectors are developed. | |
| tinyfateraser.com | 2019 | United States | – | – | Sells devices for fat reduction, body shaping, and skin firming online. | |
| samwoongtec.com | 2014 | Seoul, South Korea | – | – | Develops and produces medical injection devices using IT technology. | |
| alvalux.com | 2015 | Liege, Belgium | – | 1 | Develops innovative medical devices focused on scar therapy solutions. | |
| binom-physio.ru | 2017 | Kaluga, Russia | – | – | Offers ultrasound and laser therapy devices for medical and therapeutic applications. | |
| photontoner.com | 2019 | Manchester, United Kingdom | – | – | Develops innovative massage devices for skin tightening. |
Detailed competitors of Sebacia
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sebacia
Complete news archive for Sebacia
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Sebacia
10 companies that operate in the same segment as Sebacia (Dermatology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Neurotoxin products for aesthetic and therapeutic skin treatments are developed. | 2002 | Newark, New Jersey, United States | USD 154.56 M | USD 234.04 M | 597 | |
Diagnostic tests for cancer prognosis are provided. | 2008 | Friendswood, Texas, United States | USD 61.97 M | USD 344.23 M | 761 | |
Developer of drugs for treating dermatology diseases | 1908 | Copenhagen, Denmark | USD 560.38 M | – | – | |
Skincare, beauty, and wellness services provided by VLCC across multiple countries. | 1989 | Delhi, Delhi, India | – | – | – | |
Adhesive patch biopsies for skin cancer detection are provided. | 1996 | San Diego, California, United States | USD 24.37 M | USD 15.3 M | 259 | |
AI-powered drug discovery platform for various diseases | 2016 | New York, New York, United States | USD 608 M | – | – | |
Immunotherapeutic solutions for dermatological conditions are developed. | 2016 | Westlake Village, California, United States | USD 94.5 M | USD 376.07 M | 342 | |
Targeted small molecules are developed for oncology treatments. | 2010 | Singapore, Singapore | USD 100 M | – | – | |
Pharmaceutical formulations for dermatology, gastroenterology, and wellness are manufactured. | 2014 | Pune, Maharashtra, India | USD 25.97 M | USD 18.15 M | 508 | |
Novel dermatologic therapies are developed for skin conditions. | 2012 | Malvern, Pennsylvania, United States | USD 82 M | USD 7.83 M | 64 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Sebacia
Sebacia was founded in 2010.
Sebacia is headquartered in Duluth, United States.
Sebacia is a funded company, having raised a total of $72.73M across 10 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $2.5M, raised on Jun 2010.
Sebacia has 14 employees.
Sebacia develops topical microparticle therapies for dermatological conditions through providing healthcare solutions, producing pharmaceutical products, dermatology, and topical therapies. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
Sebacia's top competitors include Candesant, PhotoSonix Medical and Nano Ceuticals.
Sebacia has 7 investors. Key investors include Hercules Capital, Square 1 Bank, Salem Partners, Versant Ventures, and Domain Associates.
Sebacia operates through Sebacia, Inc..